IPO
Unicycive Therapeutics
Biotechnology
We are a biotechnology company dedicated to developing treatments for certain medical conditions. Currently, two of our programs are focused on kidney disease that we believe have the potential to offer medical benefit.
Symbol
UNCY
Price Range
$8.50 - $10.50
Anticipated Date
June 24, 2021
Underwriters
ROTH CAPITAL PARTNERS, LLC
This offering is no longer available
Sign Up to participate in future offerings
To view the prospectus for Unicycive Therapeutics IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277